NL-OMON53756
Recruiting
Phase 4
*Prevention of opioid-induced constipation in patients with advanced cancer* - OMAMA-study
Amsterdam UMC0 sites330 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
- Amsterdam UMC
- Enrollment
- 330
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients with advanced cancer (\>\=18 years);
- •Starting with slow release or transdermal opioids for pain;
- •Able to complete a Dutch questionnaire.
- •Previous treatment with opioids is allowed, if discontinued more than 4 weeks
Exclusion Criteria
- •Patients with contra\-indications for laxatives • Maintenance treatment with
- •laxatives during the last two weeks • Severely impaired renal function (serum
- •creatinine \>180 umol/l) • Estimated life expectancy \<1 month
Investigators
Similar Trials
Not yet recruiting
Phase 4
Prevention of opioid-associated constipation in ventilated intensive care patientsConstipationOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonAnaesthesiology - Pain managementACTRN12620000207910Dr Eamon Raith300
Active, not recruiting
Phase 1
Prevention of opioid-induced constipation in patients with advanced cancerOpioid-induced constipation in patients with advanced cancer, starting with opioids for painMedDRA version: 24.0Level: LLTClassification code 10071128Term: Opioid induced constipationSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2022-000408-36-NLZonMw330
Recruiting
Not Applicable
Observational study on opioid-induced constipation in patients with non-cancer chronic pain using weak opioid analgesics in JapaOpioid Induced ConstipationJPRN-UMIN000050203Shionogi & Co., Ltd.60
Active, not recruiting
Not Applicable
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesEUCTR2007-007610-10-NLMC Utrecht
Completed
Phase 3
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesConstipation/difficulty with bowel movements10017977NL-OMON33671niversitair Medisch Centrum Utrecht155